Stulberg B N, Dorr L D, Ranawat C S, Weksler B B, Schneider R
J Bone Joint Surg Am. 1981 Feb;63(2):288-94.
Using a biochemical assay of the prostaglandin endoperoxide metabolite malondialdehyde, platelet activity was evaluated in 147 patients who were undergoing orthopaedic surgical procedures. Assays were performed before and after operation and the results were correlated with the type of operation, the sex of the patient, and the use of aspirin as an antiplatelet-aggregation agent. Postoperatively, statistically significant elevations of platelet activity were found in patients who were not taking aspirin, while highly statistically significant suppressions of this activity were found after total hip arthroplasties and other surgical procedures in patients who had received aspirin. Men and women had similar levels of suppression of platelet aggregability with aspirin.
采用前列腺素内过氧化物代谢产物丙二醛的生化检测方法,对147例接受骨科手术的患者的血小板活性进行了评估。在手术前后进行检测,并将结果与手术类型、患者性别以及阿司匹林作为抗血小板聚集剂的使用情况相关联。术后,未服用阿司匹林的患者血小板活性有统计学意义的升高,而接受阿司匹林治疗的患者在全髋关节置换术和其他手术后,血小板活性有高度统计学意义的抑制。男性和女性服用阿司匹林后血小板聚集性的抑制水平相似。